Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.85 USD | -12.97% | -27.35% | -58.33% |
Apr. 16 | Scilex Issues Preliminary Q1 Sales Results for ZTlido | MT |
Mar. 20 | Scilex Seeks FDA Approval to Add Dosing Guidance to Gout Treatment Drug Label | MT |
Business Summary
Number of employees: 105
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Non-Opioid Pain Management Products
100.0
%
| 38 | 100.0 % | 47 | 100.0 % | +22.90% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 38 | 100.0 % | 47 | 100.0 % | +22.90% |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 226,258,420 | 103,539,600 ( 45.76 %) | 60,068,585 ( 26.55 %) | 40.55 % |
Stock B | 0 | 29,057,097 | 0 | 0 |
Company contact information
Sector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-58.33% | 90.2M | |
+5.73% | 70.78B | |
+11.35% | 9.15B | |
-15.34% | 4.84B | |
+34.54% | 4.22B | |
+5.09% | 3.92B | |
+27.76% | 2.55B | |
-28.33% | 2.24B | |
-24.15% | 2.26B | |
+6.23% | 1.92B |
- Stock Market
- Equities
- SCLX Stock
- Company Scilex Holding Company